Actinium Pharmaceuticals, Inc. (ATNM)
1.12
+0.01
(+0.90%)
USD |
NYAM |
Feb 13, 14:13
Actinium Pharmaceuticals Free Cash Flow : -25.04M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Assertio Holdings, Inc. | 13.33M |
| Altimmune, Inc. | -66.66M |
| Aldeyra Therapeutics, Inc. | -40.08M |
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.325M |
| Cash from Financing (Quarterly) | -0.209M |
| Free Cash Flow Per Share (Quarterly) | -0.2028 |
| Free Cash Flow to Equity (Quarterly) | -6.178M |
| Free Cash Flow to Firm (Quarterly) | -6.325M |
| Free Cash Flow Yield | -71.67% |